DOI: 10.1001/jamadermatol.2026.2912 ISSN: 2168-6068
Variation in Coverage of Atopic Dermatitis Therapies Across Commercial Payers
Claire H. Brennan, Sophie E. Knox, Molly T. Beinfeld, Daniel E. Enright, James D. ChambersThis economic evaluation examines the diagnostic threshold, step therapy, and prescriber requirements from commercial health plans for covering 7 US Food and Drug Administration–approved atopic dermatitis medications.